Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoglycemic Agents | 12 | 2015 | 2872 | 0.600 |
Why?
|
Diabetes Mellitus, Type 2 | 27 | 2015 | 11725 | 0.540 |
Why?
|
Diabetes Mellitus | 18 | 2013 | 5751 | 0.500 |
Why?
|
Dysthymic Disorder | 1 | 2013 | 74 | 0.460 |
Why?
|
Islets of Langerhans Transplantation | 4 | 2015 | 745 | 0.440 |
Why?
|
Insulin | 19 | 2015 | 6580 | 0.390 |
Why?
|
Diabetes Mellitus, Type 1 | 10 | 2015 | 3336 | 0.390 |
Why?
|
Inpatients | 5 | 2013 | 2518 | 0.330 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2010 | 204 | 0.330 |
Why?
|
Blood Glucose | 21 | 2015 | 6256 | 0.330 |
Why?
|
Fibronectins | 9 | 1997 | 726 | 0.300 |
Why?
|
Islets of Langerhans | 3 | 2008 | 1352 | 0.290 |
Why?
|
Endothelium, Vascular | 12 | 1997 | 4456 | 0.290 |
Why?
|
Diabetes Complications | 3 | 2003 | 1359 | 0.280 |
Why?
|
Glucose | 12 | 2006 | 4397 | 0.240 |
Why?
|
C-Peptide | 5 | 2015 | 419 | 0.230 |
Why?
|
Cushing Syndrome | 2 | 2000 | 249 | 0.220 |
Why?
|
Graft Survival | 2 | 2015 | 3737 | 0.220 |
Why?
|
Self Care | 4 | 2013 | 786 | 0.200 |
Why?
|
Hyperglycemia | 6 | 2013 | 1373 | 0.190 |
Why?
|
Megestrol | 1 | 2000 | 8 | 0.180 |
Why?
|
Peripheral Arterial Disease | 1 | 2011 | 1188 | 0.180 |
Why?
|
Shoulder | 1 | 2002 | 299 | 0.180 |
Why?
|
Diabetic Angiopathies | 7 | 2009 | 818 | 0.160 |
Why?
|
Depressive Disorder, Major | 2 | 2013 | 4644 | 0.160 |
Why?
|
Ethics, Nursing | 1 | 2017 | 25 | 0.150 |
Why?
|
Adrenal Glands | 1 | 2000 | 546 | 0.150 |
Why?
|
Extracellular Matrix | 3 | 1997 | 1741 | 0.140 |
Why?
|
Musculoskeletal Diseases | 2 | 2002 | 581 | 0.140 |
Why?
|
Hand | 1 | 2002 | 884 | 0.140 |
Why?
|
Rheumatic Diseases | 1 | 2003 | 592 | 0.140 |
Why?
|
RNA, Messenger | 14 | 1996 | 13033 | 0.140 |
Why?
|
Pregnancy in Diabetics | 2 | 1996 | 179 | 0.130 |
Why?
|
Patient Advocacy | 2 | 2017 | 353 | 0.130 |
Why?
|
Graft Rejection | 1 | 2008 | 4397 | 0.130 |
Why?
|
Diabetic Retinopathy | 5 | 2007 | 1210 | 0.130 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 1996 | 1116 | 0.120 |
Why?
|
Ergocalciferols | 1 | 2015 | 110 | 0.120 |
Why?
|
Hypoglycemia | 2 | 2015 | 861 | 0.120 |
Why?
|
Retinal Vessels | 4 | 2007 | 772 | 0.120 |
Why?
|
Basement Membrane | 3 | 1991 | 356 | 0.120 |
Why?
|
Methyl Methanesulfonate | 1 | 1993 | 27 | 0.120 |
Why?
|
Outpatient Clinics, Hospital | 3 | 2004 | 392 | 0.110 |
Why?
|
Streptozocin | 1 | 1993 | 196 | 0.110 |
Why?
|
Cell Division | 6 | 1997 | 4568 | 0.110 |
Why?
|
Research Subjects | 1 | 2014 | 239 | 0.100 |
Why?
|
Research Personnel | 1 | 2017 | 573 | 0.100 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1993 | 286 | 0.100 |
Why?
|
Heart Diseases | 1 | 2005 | 2788 | 0.100 |
Why?
|
Middle Aged | 38 | 2015 | 213383 | 0.100 |
Why?
|
Laminin | 1 | 1993 | 419 | 0.100 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2000 | 1524 | 0.100 |
Why?
|
Antipsychotic Agents | 4 | 2007 | 3057 | 0.100 |
Why?
|
Capillaries | 2 | 1991 | 773 | 0.100 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 2013 | 434 | 0.090 |
Why?
|
Insulin Resistance | 4 | 2015 | 3864 | 0.090 |
Why?
|
Blotting, Northern | 4 | 1993 | 1581 | 0.090 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1991 | 821 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2000 | 1353 | 0.090 |
Why?
|
Advisory Committees | 1 | 2014 | 775 | 0.090 |
Why?
|
Aged | 31 | 2014 | 163280 | 0.090 |
Why?
|
Glucagon | 5 | 1986 | 533 | 0.090 |
Why?
|
Delivery of Health Care | 1 | 2007 | 5319 | 0.090 |
Why?
|
Congenital Abnormalities | 2 | 1996 | 707 | 0.090 |
Why?
|
Humans | 78 | 2017 | 744343 | 0.090 |
Why?
|
Female | 52 | 2015 | 380194 | 0.080 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 2008 | 115 | 0.080 |
Why?
|
Portal Vein | 2 | 2008 | 437 | 0.080 |
Why?
|
Thiazolidinediones | 2 | 2009 | 476 | 0.080 |
Why?
|
Risk Reduction Behavior | 2 | 2013 | 1125 | 0.080 |
Why?
|
Male | 50 | 2015 | 350118 | 0.080 |
Why?
|
Schizophrenia | 5 | 2007 | 6882 | 0.080 |
Why?
|
Collagen | 3 | 1991 | 2689 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 1995 | 2007 | 0.080 |
Why?
|
Paraneoplastic Endocrine Syndromes | 1 | 1987 | 31 | 0.080 |
Why?
|
Program Development | 1 | 2014 | 1316 | 0.080 |
Why?
|
Joint Commission on Accreditation of Healthcare Organizations | 1 | 2007 | 93 | 0.080 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 1987 | 30 | 0.080 |
Why?
|
Cyclic AMP | 1 | 1991 | 1472 | 0.070 |
Why?
|
Gene Expression Regulation | 5 | 1993 | 12072 | 0.070 |
Why?
|
Adult | 37 | 2015 | 214055 | 0.070 |
Why?
|
Injections, Subcutaneous | 1 | 2008 | 666 | 0.070 |
Why?
|
Family Practice | 2 | 2007 | 516 | 0.070 |
Why?
|
Fatal Outcome | 2 | 2008 | 1850 | 0.070 |
Why?
|
Potassium | 4 | 1986 | 1336 | 0.070 |
Why?
|
Umbilical Veins | 6 | 1997 | 433 | 0.070 |
Why?
|
Boston | 4 | 2017 | 9313 | 0.070 |
Why?
|
Coronary Restenosis | 1 | 2009 | 424 | 0.070 |
Why?
|
Dibenzothiazepines | 1 | 2006 | 103 | 0.070 |
Why?
|
Vitamin D Deficiency | 1 | 2015 | 1343 | 0.070 |
Why?
|
Counseling | 1 | 2013 | 1523 | 0.070 |
Why?
|
Corticotropin-Releasing Hormone | 1 | 1987 | 369 | 0.070 |
Why?
|
Medication Adherence | 2 | 2013 | 2063 | 0.060 |
Why?
|
Specialization | 2 | 2007 | 777 | 0.060 |
Why?
|
Autopsy | 1 | 2008 | 1020 | 0.060 |
Why?
|
RNA | 2 | 1993 | 2749 | 0.060 |
Why?
|
Vasodilator Agents | 1 | 2009 | 977 | 0.060 |
Why?
|
Hypercholesterolemia | 2 | 2002 | 1151 | 0.060 |
Why?
|
Health Status Indicators | 2 | 2008 | 969 | 0.060 |
Why?
|
Cells, Cultured | 13 | 1997 | 19229 | 0.060 |
Why?
|
Diabetic Ketoacidosis | 1 | 2007 | 245 | 0.060 |
Why?
|
Atrophy | 1 | 2008 | 1583 | 0.060 |
Why?
|
Interleukin-1 | 3 | 1993 | 1263 | 0.060 |
Why?
|
Adenocarcinoma | 2 | 2000 | 6364 | 0.060 |
Why?
|
DNA Damage | 1 | 1993 | 2432 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2015 | 3297 | 0.050 |
Why?
|
Mass Screening | 2 | 2008 | 5255 | 0.050 |
Why?
|
Disease Management | 2 | 2004 | 2459 | 0.050 |
Why?
|
von Willebrand Factor | 4 | 1994 | 669 | 0.050 |
Why?
|
Patient Education as Topic | 2 | 2005 | 2278 | 0.050 |
Why?
|
Plasminogen Inactivators | 2 | 1992 | 38 | 0.050 |
Why?
|
Treatment Failure | 1 | 2008 | 2618 | 0.050 |
Why?
|
Cerebral Infarction | 1 | 2007 | 1011 | 0.050 |
Why?
|
Tenosynovitis | 1 | 2002 | 57 | 0.050 |
Why?
|
Reference Values | 2 | 2008 | 4982 | 0.050 |
Why?
|
Evidence-Based Medicine | 4 | 2014 | 3610 | 0.050 |
Why?
|
Models, Theoretical | 1 | 2014 | 3589 | 0.050 |
Why?
|
Internet | 2 | 2005 | 3064 | 0.050 |
Why?
|
Superoxide Dismutase | 2 | 1996 | 597 | 0.050 |
Why?
|
Bursitis | 1 | 2002 | 83 | 0.050 |
Why?
|
Dupuytren Contracture | 1 | 2002 | 62 | 0.050 |
Why?
|
Hemodynamics | 2 | 2007 | 4199 | 0.050 |
Why?
|
Clozapine | 2 | 2005 | 498 | 0.050 |
Why?
|
Medicine | 2 | 2007 | 946 | 0.050 |
Why?
|
Hemoglobins | 1 | 2007 | 1534 | 0.050 |
Why?
|
Patient Compliance | 2 | 2008 | 2684 | 0.050 |
Why?
|
Hypertonic Solutions | 3 | 1995 | 93 | 0.050 |
Why?
|
Primary Health Care | 4 | 2007 | 4558 | 0.050 |
Why?
|
Hypolipidemic Agents | 1 | 2005 | 604 | 0.050 |
Why?
|
Glucose Tolerance Test | 4 | 2008 | 1150 | 0.050 |
Why?
|
Retina | 3 | 2007 | 2616 | 0.050 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1177 | 0.040 |
Why?
|
Giant Cell Tumor of Bone | 1 | 2000 | 116 | 0.040 |
Why?
|
Risk Factors | 11 | 2015 | 72290 | 0.040 |
Why?
|
Evoked Potentials, Visual | 1 | 2001 | 427 | 0.040 |
Why?
|
Attitude to Health | 1 | 2008 | 2052 | 0.040 |
Why?
|
Drug Costs | 1 | 2006 | 1105 | 0.040 |
Why?
|
Proteins | 2 | 1993 | 6103 | 0.040 |
Why?
|
Societies, Medical | 2 | 2007 | 3743 | 0.040 |
Why?
|
Quality Improvement | 1 | 2014 | 3749 | 0.040 |
Why?
|
Depressive Disorder | 2 | 2008 | 3748 | 0.040 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2002 | 300 | 0.040 |
Why?
|
Actins | 4 | 1997 | 2121 | 0.040 |
Why?
|
Clinical Competence | 1 | 2014 | 4687 | 0.040 |
Why?
|
Body Weight | 3 | 2006 | 4669 | 0.040 |
Why?
|
Hypertension | 4 | 2006 | 8480 | 0.040 |
Why?
|
Kinetics | 4 | 1993 | 6473 | 0.040 |
Why?
|
Visual Pathways | 1 | 2001 | 565 | 0.040 |
Why?
|
Acute Disease | 1 | 2007 | 7149 | 0.040 |
Why?
|
Emergency Service, Hospital | 2 | 2008 | 7659 | 0.040 |
Why?
|
Prevalence | 3 | 2008 | 15226 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2000 | 578 | 0.030 |
Why?
|
Young Adult | 5 | 2015 | 56430 | 0.030 |
Why?
|
Feedback | 1 | 1999 | 795 | 0.030 |
Why?
|
Odds Ratio | 2 | 2006 | 9849 | 0.030 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2015 | 39 | 0.030 |
Why?
|
Adolescent | 8 | 2014 | 85781 | 0.030 |
Why?
|
Tissue Plasminogen Activator | 2 | 1992 | 1261 | 0.030 |
Why?
|
Free Radical Scavengers | 1 | 1996 | 216 | 0.030 |
Why?
|
Antihypertensive Agents | 1 | 2005 | 2046 | 0.030 |
Why?
|
Stress, Psychological | 2 | 2008 | 4245 | 0.030 |
Why?
|
Prednisone | 1 | 2000 | 1574 | 0.030 |
Why?
|
Gene Expression | 4 | 2000 | 7799 | 0.030 |
Why?
|
Blood Platelets | 2 | 1983 | 2508 | 0.030 |
Why?
|
Calcifediol | 1 | 2015 | 166 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2005 | 2585 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1995 | 537 | 0.030 |
Why?
|
Vision Disorders | 1 | 2001 | 1058 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 3 | 1996 | 8301 | 0.030 |
Why?
|
Rats, Mutant Strains | 1 | 1993 | 70 | 0.030 |
Why?
|
Linear Models | 2 | 2005 | 5952 | 0.030 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1993 | 79 | 0.030 |
Why?
|
Poly A | 1 | 1993 | 185 | 0.030 |
Why?
|
Transcription Factor CHOP | 1 | 1993 | 73 | 0.030 |
Why?
|
Aged, 80 and over | 5 | 2010 | 57776 | 0.030 |
Why?
|
Transcription Factors | 1 | 1993 | 12208 | 0.030 |
Why?
|
Recombinant Proteins | 3 | 1993 | 6622 | 0.030 |
Why?
|
Cross-Sectional Studies | 4 | 2008 | 25043 | 0.030 |
Why?
|
Coronary Disease | 2 | 2005 | 6077 | 0.030 |
Why?
|
Insulinoma | 1 | 1993 | 124 | 0.030 |
Why?
|
Physician's Role | 1 | 1999 | 943 | 0.030 |
Why?
|
Cohort Studies | 7 | 2015 | 40561 | 0.030 |
Why?
|
Patient Care Team | 1 | 2004 | 2531 | 0.030 |
Why?
|
DNA Probes | 1 | 1993 | 560 | 0.030 |
Why?
|
Blood Pressure | 2 | 2005 | 8554 | 0.030 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 1991 | 102 | 0.030 |
Why?
|
Hyperkalemia | 3 | 1983 | 218 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 1997 | 1364 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2015 | 39050 | 0.020 |
Why?
|
RNA Probes | 1 | 1991 | 113 | 0.020 |
Why?
|
Transcription, Genetic | 5 | 1992 | 7722 | 0.020 |
Why?
|
Fibrinolysis | 1 | 1992 | 322 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2000 | 3479 | 0.020 |
Why?
|
Microbial Collagenase | 1 | 1991 | 122 | 0.020 |
Why?
|
Rats | 5 | 1996 | 24260 | 0.020 |
Why?
|
Sialoglycoproteins | 1 | 1992 | 318 | 0.020 |
Why?
|
Patient Selection | 1 | 2003 | 4215 | 0.020 |
Why?
|
United States | 6 | 2008 | 69872 | 0.020 |
Why?
|
Depression | 2 | 2007 | 7766 | 0.020 |
Why?
|
Hyperlipidemias | 2 | 2006 | 789 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2017 | 2539 | 0.020 |
Why?
|
Benzodiazepines | 2 | 2006 | 1101 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1991 | 1375 | 0.020 |
Why?
|
Cricetinae | 1 | 1993 | 2472 | 0.020 |
Why?
|
Up-Regulation | 2 | 1995 | 4217 | 0.020 |
Why?
|
Blood Vessels | 2 | 1985 | 1125 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 1801 | 0.020 |
Why?
|
Hemostasis | 1 | 1991 | 458 | 0.020 |
Why?
|
Molecular Weight | 1 | 1991 | 2255 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2015 | 12026 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 840 | 0.020 |
Why?
|
Qualitative Research | 1 | 2017 | 2682 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2000 | 2529 | 0.020 |
Why?
|
Metyrapone | 1 | 1987 | 23 | 0.020 |
Why?
|
Body Mass Index | 4 | 2008 | 12720 | 0.020 |
Why?
|
Registries | 3 | 2012 | 8089 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2007 | 242 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2002 | 21746 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2003 | 7913 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 1993 | 1701 | 0.020 |
Why?
|
Thromboplastin | 1 | 1989 | 291 | 0.020 |
Why?
|
Arginine | 2 | 1981 | 944 | 0.020 |
Why?
|
Somatostatin | 3 | 1986 | 459 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1504 | 0.020 |
Why?
|
Health Surveys | 2 | 2007 | 4037 | 0.020 |
Why?
|
Protein Kinase C | 1 | 1991 | 1227 | 0.020 |
Why?
|
Thrombin | 1 | 1989 | 598 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2000 | 10943 | 0.020 |
Why?
|
Risk | 3 | 2015 | 9687 | 0.020 |
Why?
|
Prognosis | 3 | 2015 | 29063 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 1993 | 6314 | 0.020 |
Why?
|
Platelet Adhesiveness | 2 | 1983 | 161 | 0.020 |
Why?
|
Retreatment | 1 | 2006 | 610 | 0.020 |
Why?
|
Sickness Impact Profile | 1 | 2006 | 302 | 0.020 |
Why?
|
Physicians, Family | 1 | 2007 | 345 | 0.020 |
Why?
|
Demyelinating Diseases | 1 | 2007 | 354 | 0.020 |
Why?
|
Quality of Life | 1 | 2006 | 12804 | 0.020 |
Why?
|
Gestational Age | 1 | 1993 | 3493 | 0.020 |
Why?
|
Nursing Assessment | 1 | 2004 | 107 | 0.020 |
Why?
|
Health Behavior | 2 | 2007 | 2636 | 0.020 |
Why?
|
Muscle Weakness | 1 | 2007 | 413 | 0.020 |
Why?
|
Protein Kinases | 1 | 1991 | 1640 | 0.010 |
Why?
|
Hospitalization | 1 | 2004 | 10262 | 0.010 |
Why?
|
Phenylacetates | 1 | 1983 | 114 | 0.010 |
Why?
|
Opportunistic Infections | 1 | 2006 | 389 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2014 | 2266 | 0.010 |
Why?
|
Vasculitis | 1 | 2007 | 519 | 0.010 |
Why?
|
Age Factors | 3 | 2006 | 18370 | 0.010 |
Why?
|
Nutrition Assessment | 1 | 2006 | 723 | 0.010 |
Why?
|
Clonidine | 1 | 1983 | 164 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2012 | 63114 | 0.010 |
Why?
|
Pancreatic Neoplasms | 2 | 1993 | 5256 | 0.010 |
Why?
|
Guanidines | 1 | 1983 | 193 | 0.010 |
Why?
|
Isoantibodies | 1 | 2006 | 679 | 0.010 |
Why?
|
Coronary Stenosis | 1 | 2009 | 834 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2009 | 15076 | 0.010 |
Why?
|
Age Distribution | 1 | 2008 | 2902 | 0.010 |
Why?
|
Risperidone | 1 | 2005 | 383 | 0.010 |
Why?
|
Arginine Vasopressin | 1 | 1982 | 130 | 0.010 |
Why?
|
Deamino Arginine Vasopressin | 1 | 1982 | 91 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2373 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2007 | 12959 | 0.010 |
Why?
|
Comorbidity | 2 | 2006 | 10388 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 2006 | 2274 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 2008 | 1660 | 0.010 |
Why?
|
Employment | 1 | 2008 | 1132 | 0.010 |
Why?
|
Medical Records | 1 | 2007 | 1413 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2009 | 1873 | 0.010 |
Why?
|
Goals | 1 | 2006 | 706 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 2006 | 738 | 0.010 |
Why?
|
Quality of Health Care | 2 | 2006 | 4371 | 0.010 |
Why?
|
Choice Behavior | 1 | 2007 | 803 | 0.010 |
Why?
|
Curriculum | 1 | 2014 | 3605 | 0.010 |
Why?
|
Naloxone | 1 | 1983 | 367 | 0.010 |
Why?
|
Lipoproteins, LDL | 1 | 1984 | 640 | 0.010 |
Why?
|
Growth Hormone | 1 | 1983 | 705 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 15165 | 0.010 |
Why?
|
Brain | 1 | 2007 | 26385 | 0.010 |
Why?
|
Contrast Sensitivity | 1 | 2001 | 244 | 0.010 |
Why?
|
Fatigue | 1 | 2007 | 1531 | 0.010 |
Why?
|
Attitude of Health Personnel | 2 | 2004 | 3843 | 0.010 |
Why?
|
Dexamethasone | 1 | 1987 | 1951 | 0.010 |
Why?
|
Rats, Inbred Strains | 2 | 1992 | 2186 | 0.010 |
Why?
|
Patient Discharge | 1 | 2012 | 3313 | 0.010 |
Why?
|
Blood Coagulation Factors | 1 | 1982 | 355 | 0.010 |
Why?
|
Transplantation Conditioning | 1 | 2006 | 1598 | 0.010 |
Why?
|
Animals | 6 | 1996 | 168757 | 0.010 |
Why?
|
Headache | 1 | 2007 | 1226 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2015 | 13989 | 0.010 |
Why?
|
Administration, Oral | 1 | 2007 | 3913 | 0.010 |
Why?
|
Probability | 1 | 2004 | 2505 | 0.010 |
Why?
|
Medical Staff, Hospital | 1 | 2003 | 603 | 0.010 |
Why?
|
DNA Replication | 1 | 1985 | 1399 | 0.010 |
Why?
|
Cell Survival | 2 | 1985 | 5882 | 0.010 |
Why?
|
Cytochalasin D | 1 | 1997 | 92 | 0.010 |
Why?
|
Vinculin | 1 | 1997 | 62 | 0.010 |
Why?
|
Valproic Acid | 1 | 2000 | 445 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15540 | 0.010 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 1997 | 112 | 0.010 |
Why?
|
Health Resources | 1 | 2004 | 911 | 0.010 |
Why?
|
Pregnancy | 3 | 1996 | 29144 | 0.010 |
Why?
|
Area Under Curve | 1 | 2001 | 1654 | 0.010 |
Why?
|
Educational Status | 1 | 2005 | 2540 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 1993 | 8428 | 0.010 |
Why?
|
Hypertriglyceridemia | 1 | 2000 | 293 | 0.010 |
Why?
|
Ambulatory Care Facilities | 1 | 2003 | 933 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2009 | 4577 | 0.010 |
Why?
|
Cell Cycle | 1 | 1985 | 2967 | 0.010 |
Why?
|
Stents | 1 | 2009 | 3280 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 1997 | 428 | 0.010 |
Why?
|
Culture Media | 2 | 1992 | 908 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2006 | 5078 | 0.010 |
Why?
|
Phosphates | 1 | 1980 | 786 | 0.010 |
Why?
|
Obesity | 3 | 2005 | 12745 | 0.010 |
Why?
|
Social Class | 1 | 2005 | 1999 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2007 | 2576 | 0.010 |
Why?
|
Health Services Research | 1 | 2004 | 1836 | 0.010 |
Why?
|
Catalase | 1 | 1996 | 222 | 0.010 |
Why?
|
Incidence | 2 | 2007 | 20947 | 0.010 |
Why?
|
Amiloride | 1 | 1995 | 121 | 0.010 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 248 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2006 | 2708 | 0.010 |
Why?
|
Glutathione Peroxidase | 1 | 1996 | 255 | 0.010 |
Why?
|
Migraine Disorders | 1 | 2007 | 1620 | 0.010 |
Why?
|
Culture Techniques | 1 | 1995 | 554 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2008 | 12245 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2008 | 7785 | 0.010 |
Why?
|
Skin | 1 | 2007 | 4364 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2006 | 4149 | 0.010 |
Why?
|
Trypsin | 1 | 1994 | 511 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2004 | 2759 | 0.010 |
Why?
|
Health Care Costs | 1 | 2006 | 3209 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2007 | 77449 | 0.010 |
Why?
|
Methylurea Compounds | 1 | 1992 | 3 | 0.010 |
Why?
|
Time Factors | 2 | 1993 | 40075 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4751 | 0.010 |
Why?
|
Health Status | 1 | 2006 | 4034 | 0.010 |
Why?
|
Phenanthrolines | 1 | 1992 | 55 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 1996 | 1799 | 0.010 |
Why?
|
Visual Acuity | 1 | 2001 | 2530 | 0.010 |
Why?
|
Triglycerides | 1 | 2000 | 2454 | 0.010 |
Why?
|
Diuretics | 1 | 1995 | 592 | 0.010 |
Why?
|
Disease Progression | 1 | 2009 | 13284 | 0.010 |
Why?
|
Dactinomycin | 1 | 1992 | 318 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2007 | 4931 | 0.010 |
Why?
|
Endothelium | 2 | 1985 | 778 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1996 | 1950 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1992 | 475 | 0.010 |
Why?
|
DNA Primers | 1 | 1996 | 2892 | 0.010 |
Why?
|
Cholesterol | 1 | 2000 | 2917 | 0.010 |
Why?
|
Massachusetts | 1 | 2004 | 8663 | 0.010 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 1992 | 297 | 0.010 |
Why?
|
Cell Adhesion | 1 | 1997 | 3144 | 0.010 |
Why?
|
Factor VIII | 2 | 1983 | 347 | 0.010 |
Why?
|
Length of Stay | 1 | 2004 | 6309 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1990 | 186 | 0.010 |
Why?
|
Sodium | 1 | 1995 | 1623 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1994 | 2505 | 0.010 |
Why?
|
Platelet Aggregation | 2 | 1983 | 798 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2006 | 7279 | 0.010 |
Why?
|
Family | 1 | 2000 | 3147 | 0.010 |
Why?
|
Software | 1 | 2003 | 4443 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2006 | 19905 | 0.000 |
Why?
|
Diabetic Nephropathies | 1 | 1995 | 984 | 0.000 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1994 | 2649 | 0.000 |
Why?
|
Thiophenes | 1 | 1992 | 588 | 0.000 |
Why?
|
Antigens | 2 | 1983 | 1466 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 2000 | 11366 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6171 | 0.000 |
Why?
|
Aldosterone | 2 | 1981 | 877 | 0.000 |
Why?
|
Algorithms | 1 | 2006 | 13881 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 2007 | 8863 | 0.000 |
Why?
|
Hepatic Veins | 1 | 1986 | 112 | 0.000 |
Why?
|
Psychotic Disorders | 1 | 2000 | 3046 | 0.000 |
Why?
|
Physicians | 1 | 2003 | 4567 | 0.000 |
Why?
|
Genes | 1 | 1989 | 1893 | 0.000 |
Why?
|
Mannitol | 1 | 1985 | 181 | 0.000 |
Why?
|
Base Sequence | 1 | 1996 | 12797 | 0.000 |
Why?
|
beta-Thromboglobulin | 1 | 1983 | 24 | 0.000 |
Why?
|
Indium | 1 | 1983 | 46 | 0.000 |
Why?
|
Guanfacine | 1 | 1983 | 51 | 0.000 |
Why?
|
Receptors, Opioid | 1 | 1983 | 155 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 18111 | 0.000 |
Why?
|
Adrenergic alpha-Agonists | 1 | 1983 | 177 | 0.000 |
Why?
|
Radioisotopes | 1 | 1983 | 499 | 0.000 |
Why?
|
Platelet Function Tests | 1 | 1983 | 270 | 0.000 |
Why?
|
California | 1 | 1985 | 1402 | 0.000 |
Why?
|
Infusions, Parenteral | 1 | 1981 | 419 | 0.000 |
Why?
|
Cell Count | 1 | 1985 | 1856 | 0.000 |
Why?
|
Methylation | 1 | 1984 | 1106 | 0.000 |
Why?
|
Osmolar Concentration | 1 | 1981 | 683 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2007 | 35421 | 0.000 |
Why?
|
Seasons | 1 | 1985 | 1493 | 0.000 |
Why?
|
Prospective Studies | 1 | 2004 | 53288 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2000 | 17446 | 0.000 |
Why?
|
Aorta | 1 | 1986 | 2061 | 0.000 |
Why?
|
Myocardium | 1 | 1990 | 4776 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1981 | 2557 | 0.000 |
Why?
|
Blood Proteins | 1 | 1981 | 1124 | 0.000 |
Why?
|
Signal Transduction | 1 | 1995 | 23403 | 0.000 |
Why?
|
Sex Factors | 1 | 1985 | 10397 | 0.000 |
Why?
|
Child | 2 | 1985 | 77709 | 0.000 |
Why?
|
Child, Preschool | 1 | 1985 | 41006 | 0.000 |
Why?
|